Angiotensin Converting Enzyme 2 News and Research

RSS

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Researchers have investigated the pathology and inflammatory response to the Delta variant in mice.

24 Jan 2022

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Researchers have been investigating the potential for using nanobodies – special immune particles from llamas and alpacas – against the disease.

24 Jan 2022

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

A recent study published in the journal Science brings a detailed chemical and molecular perspective on the improved evasion of antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the retention of strong interactions with the receptor as two principal factors underneath the notorious transmissibility of the SARS-CoV-2 Omicron variant.

23 Jan 2022

Novel SARS-CoV-2 mutations reported in chronic HIV patients

A new study describes the emergence of new SARS-CoV-2 variants in three immunocompromised patients.

23 Jan 2022

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Researchers describe the state of adaptive immunity following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

23 Jan 2022

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

A new study showed that the SARS-CoV-2 Omicron spike binds to its receptor with enhanced affinity and yet evades vaccine-elicited neutralizing antibodies and that a booster mRNA vaccine broadened the neutralization of Omicron.

21 Jan 2022

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

A new study aimed to understand the risk of COVID-19 infection given certain serological parameters, in a group of vaccinated healthcare workers with high rates of exposure to the virus, followed up at 9 months from vaccination.

20 Jan 2022

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Researchers investigated the effectiveness of the SARS-CoV-2 Omicron-variant induced immunity, whether it is cross-protective against other variants, and if earlier infection with the SARS-CoV-2 Delta variant offers protection against Omicron.

20 Jan 2022

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

Researchers investigated the binding behavior of spike protein and receptor-binding domain of SARS-CoV-2 under different environmental conditions.

20 Jan 2022

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Researchers investigate the cross-reactivity of the SARS-CoV-2 with pre-pandemic malaria-exposed sera samples collected from Cambodia.

19 Jan 2022

Variants of SARS-CoV-2 and preventive strategies

A recent review article published in the journal Advanced Science reviewed the features of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants. Using a physical and materials science perspective, the review also summarizes the most significant variants of SARS-CoV-2 encountered to date as well as possible preventive strategies.

19 Jan 2022

How does SARS-CoV-2 infection impact female fertility?

In a recent study published in the journal International Journal of Environmental Research and Public Health, a team of researchers reviewed published literature that assessed the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on female reproductive health.

19 Jan 2022

Angiotensin Converting Enzyme 2 News and Research

Characterization of unique pathogenesis of SARS-CoV-2 Delta variant in mouse model

Alpaca-derived antibody fragment disrupts interaction between SARS-CoV-2 spike protein and human ACE2

Study shows how SARS-CoV-2 Omicron evades our immune response and remains infective

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Study suggests SARS-CoV-2 Omicron variant spike mediated immune escape and tropism shift

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

A novel assay for the rapid detection of SARS-CoV-2 variants

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Variants of SARS-CoV-2 and preventive strategies

How does SARS-CoV-2 infection impact female fertility?

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

Researchers investigate whether influenza impacted the epidemiological dynamics of SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Impact of COVID-19 on male and female reproductive health

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News